Abstract |
Analysis of imported malaria in travelers may represent a novel surveillance system for drug-resistant malaria. We analyzed consecutive falciparum malaria isolates from Canadian travelers from 1994 to 2000, for polymorphisms in pfcrt, dhfr, and dhps linked to chloroquine and pyrimethamine/ sulfadoxine resistance. Forty percent of isolates possessed the K76 pfcrt allele, suggesting that many imported falciparum infections are still responsive to chloroquine. Travelers who had recently taken chloroquine had a significantly increased risk of harboring isolates with pfcrt resistance alleles (odds ratio = 4.47; p=0.03). The presence of two or more mutations in dhfr or dhps was found in 64.8% (95% confidence interval [CI] 54.6 to 73.9) and in 30.4% (95% CI 21.7 to 40.3) of isolates, respectively, and increased significantly over the course of the study. These molecular markers indicate that pyrimethamine/ sulfadoxine resistance is increasing and is now too high to rely on this drug as a routine therapeutic agent to treat malaria in travelers.
|
Authors | Annie-Claude Labbé, Samir Patel, Ian Crandall, Kevin C Kain |
Journal | Emerging infectious diseases
(Emerg Infect Dis)
Vol. 9
Issue 1
Pg. 33-6
(Jan 2003)
ISSN: 1080-6040 [Print] United States |
PMID | 12533279
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antimalarials
- Genetic Markers
- Protozoan Proteins
- Sulfadoxine
- Chloroquine
- Pyrimethamine
|
Topics |
- Adolescent
- Adult
- Aged
- Animals
- Antimalarials
(pharmacology)
- Child
- Child, Preschool
- Chloroquine
(pharmacology)
- Drug Resistance
(genetics)
- Female
- Genetic Markers
- Humans
- Infant
- Malaria, Falciparum
(epidemiology, parasitology)
- Male
- Middle Aged
- Mutation
- Plasmodium falciparum
(drug effects, genetics)
- Population Surveillance
- Protozoan Proteins
(genetics)
- Pyrimethamine
(pharmacology)
- Sulfadoxine
(pharmacology)
- Travel
|